Thermo Fisher Scientific (TMO) Gross Profit (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Gross Profit for 18 consecutive years, with $8.3 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 9.56% year-over-year to $8.3 billion; the trailing twelve-month figure through Jun 2026 stood at $32.3 billion (up 6.22% YoY), and the FY2025 full-year result was $31.2 billion, up 3.06% from the prior year.
• Gross Profit improved to $8.3 billion in Q2 2026 per TMO's latest filing, from $7.7 billion in the prior quarter.
• Across five years, Gross Profit topped out at $8.5 billion in Q4 2025 and bottomed at $7.1 billion in Q1 2024.
• Historically, Gross Profit has averaged $7.6 billion across 5 years, with a median of $7.5 billion in 2022.
• The widest YoY moves for Gross Profit: up 25.89% in 2022, down 22.74% in 2022.
• Over 5 years, Gross Profit stood at $7.8 billion in 2022, then slipped by 2.85% to $7.5 billion in 2023, then climbed by 8.07% to $8.2 billion in 2024, then advanced by 4.13% to $8.5 billion in 2025, then decreased by 1.75% to $8.3 billion in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $8.3 billion, $7.7 billion, and $8.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.